Lee Ainslie's SNY Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 24,581 shares of Sanofi (SNY) worth $1.18 M, representing 0.01% of the portfolio. First purchased in 2015-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Lee Ainslie has maintained a strategic position in SNY, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2016, adding 42,790 shares. Largest reduction occurred in Q1 2016, reducing 91,300 shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Sanofi (SNY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sanofi (SNY) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +24,581 | New Buy | 24,581 | $48.18 |
| Q2 2023 | -8,634 | Sold Out | 0 | $0.00 |
| Q1 2023 | +3,459 | Add 66.84% | 8,634 | $54.42 |
| Q4 2022 | +5,175 | New Buy | 5,175 | $48.43 |
| Q3 2016 | -42,790 | Sold Out | 0 | $0.00 |
| Q2 2016 | +42,790 | New Buy | 42,790 | $41.86 |
| Q1 2016 | -91,300 | Sold Out | 0 | $0.00 |
| Q4 2015 | -10,350 | Reduce 10.18% | 91,300 | $42.65 |
| Q2 2015 | +101,650 | New Buy | 101,650 | $49.53 |
Lee Ainslie's Sanofi Investment FAQs
Lee Ainslie first purchased Sanofi (SNY) in Q2 2015, acquiring 101,650 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Sanofi (SNY) for 10 quarters since Q2 2015.
Lee Ainslie's largest addition to Sanofi (SNY) was in Q2 2015, adding 101,650 shares worth $5.04 M.
According to the latest 13F filing for Q1 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 24,581 shares of Sanofi (SNY), valued at approximately $1.18 M.
As of the Q1 2026 filing, Sanofi (SNY) represents approximately 0.01% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in Sanofi (SNY) was 101,650 shares, as reported at the end of Q2 2015.